المؤلفون: Melzer Cohen, Cheli, Schechter, Meir, Rozenberg, Aliza, Yanuv, Ilan, Sehtman-Shachar, Dvora R., Fishkin, Alisa, Rosenzweig, Doron, Chodick, Gabriel, Karasik, Avraham, Mosenzon, Ofri

المصدر: Melzer Cohen , C , Schechter , M , Rozenberg , A , Yanuv , I , Sehtman-Shachar , D R , Fishkin , A , Rosenzweig , D , Chodick , G , Karasik , A & Mosenzon , O 2023 , ' Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease ' , Clinical journal of the American Society of Nephrology : CJASN , vol. 18 , no. 9 , pp. 1153-1162 . https://doi.org/10.2215/CJN.0000000000000218Test

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/b366eb46-ce26-499d-a6ad-5f9329b24217Test

الإتاحة: https://doi.org/10.2215/CJN.0000000000000218Test
https://hdl.handle.net/11370/b366eb46-ce26-499d-a6ad-5f9329b24217Test
https://research.rug.nl/en/publications/b366eb46-ce26-499d-a6ad-5f9329b24217Test
https://pure.rug.nl/ws/files/784835508/long_term_real_world_kidney_outcomes_with_sglt2i.10.pdfTest

المؤلفون: Schechter, Meir, Melzer Cohen, Cheli, Fishkin, Alisa, Rozenberg, Aliza, Yanuv, Ilan, Sehtman-Shachar, Dvora R., Chodick, Gabriel, Clark, Alice, Abrahamsen, Trine J., Lawson, Jack, Karasik, Avraham, Mosenzon, Ofri

المصدر: Schechter , M , Melzer Cohen , C , Fishkin , A , Rozenberg , A , Yanuv , I , Sehtman-Shachar , D R , Chodick , G , Clark , A , Abrahamsen , T J , Lawson , J , Karasik , A & Mosenzon , O 2023 , ' Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes : real-world evidence ' , Cardiovascular Diabetology , vol. 22 , 126 . https://doi.org/10.1186/s12933-023-01829-0Test

مصطلحات موضوعية: Albuminuria, Basal insulin, Chronic kidney disease, eGFR slope, GLP-1 RA, Real world, Real world evidence, Type 2 diabetes

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/70d3dbbb-b390-4e97-b3e3-a4e7d1433efbTest

الإتاحة: https://doi.org/10.1186/s12933-023-01829-0Test
https://hdl.handle.net/11370/70d3dbbb-b390-4e97-b3e3-a4e7d1433efbTest
https://research.rug.nl/en/publications/70d3dbbb-b390-4e97-b3e3-a4e7d1433efbTest
https://pure.rug.nl/ws/files/781653250/s12933-023-01829-0.pdfTest

المؤلفون: Schechter, Meir, Melzer Cohen, Cheli, Fishkin, Alisa, Rozenberg, Aliza, Yanuv, Ilan, Sehtman-Shachar, Dvora R., Chodick, Gabriel, Clark, Alice, Abrahamsen, Trine J., Lawson, Jack, Karasik, Avraham, Mosenzon, Ofri

المصدر: Cardiovascular Diabetology; 6/12/2023, Vol. 22 Issue 1, p1-12, 12p

مصطلحات موضوعية: KIDNEY physiology, TYPE 2 diabetes, GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, ALBUMINURIA

مصطلحات جغرافية: ISRAEL